Biofy Participates in the Oracle Data & AI Forum in São Paulo

Biofy Technologies was present at the Oracle Data & AI Forum, held in São Paulo, where the company's CEO, Paulo Perez, presented innovations developed by the Biofy Genomics team, one of the branches of the Biofy ecosystem. The lecture was given alongside the president and vice president of Oracle in Brazil, highlighting the collaboration between the companies to promote the use of Artificial Intelligence and advanced technologies across various sectors.

Among the solutions presented, Biofy Genomics revealed Abby, an AI-based antibiotic recommender that promises to revolutionize the treatment of infections. Abby's technology uses genetic sequencing to identify the present pathogens and recommend the most effective antibiotics, offering a more precise and agile solution.

To learn more about Abby, visit: Click here to learn more.

During the event, present journalists had the opportunity to test the solution. Samples collected before the event were analyzed in record time of up to 4 hours, in contrast to conventional tests, which can take up to 5 days to complete without the assistance of AI. The speed and accuracy of Abby demonstrate how artificial intelligence can optimize laboratory processes, providing faster and more accurate results, directly benefiting the health and biotechnology sector.

"We are increasingly committed to developing solutions that combine biotechnology and artificial intelligence to transform how health is treated in Brazil and around the world," said Paulo Perez. The partnership with Oracle, in addition to offering support in technology, has been fundamental for the development of tools like Abby, which has the potential to transform medical diagnostics and treatments, positively impacting efficiency in the sector.

This event reflects Biofy Technologies' ongoing commitment to innovation and the use of AI to solve complex problems, ensuring quick and effective results for global health.